SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer. - Mayer, E. L.; Dhakil, S.; Patel, T.; Sundaram, S.; Fabian, C.; Kozloff, M.; Qamar, R.; Volterra, F.; Parmar, H.; Samant, M.; Burstein, H. J. (Annals of Oncology, 2010)